
Eli Lilly’s Retatrutide Weight Loss Trial Shows Near-Surgical Results in New Study
Eli Lilly’s retatrutide weight loss trial has delivered some of the strongest obesity treatment results ever reported in a late-stage
Eli Lilly’s retatrutide weight loss trial has delivered some of the strongest obesity treatment results ever reported in a late-stage clinical study. …
The diphtheria outbreak in Australia is becoming one of the country’s largest infectious disease events in decades, with cases spreading beyond the …
President Donald Trump announced a major update to the TrumpRx prescription platform, unveiling a large-scale TrumpRx expansion with generic drug discounts aimed …
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Baxfendy (baxdrostat) as a first-in-class hypertension therapy designed for patients living with …
A new Ebola outbreak in Congo has triggered urgent health warnings across Central Africa after officials reported 246 suspected cases and 65 …
A major new study on antidepressants in pregnancy is offering reassurance to millions of families concerned about how antidepressants will affect their …
A historic healthcare effort has led to a major shift in women’s health terminology. The condition PCOS has officially been renamed by …
The Hantavirus outbreak on cruise ship MV Hondius is continuously growing. It has prompted international health agencies to launch large-scale infectious disease …
The UK public health officials have issued an urgent alert following a Hepatitis A outbreak in Wales, after several linked infections were …
Eli Lilly and Company is investing another $4.5 billion into its Indiana operations as the drugmaker expands production of obesity treatments and …
The U.S. Food and Drug Administration (FDA) has authorized the marketing of four new electronic nicotine delivery systems (ENDS), signaling a new …
The U.S. Food and Drug Administration (FDA) blocks publication of vaccine research on several studies examining their safety, sparking debate over scientific …

Eli Lilly’s retatrutide weight loss trial has delivered some of the strongest obesity treatment results ever reported in a late-stage

The diphtheria outbreak in Australia is becoming one of the country’s largest infectious disease events in decades, with cases spreading

President Donald Trump announced a major update to the TrumpRx prescription platform, unveiling a large-scale TrumpRx expansion with generic drug

The US Food and Drug Administration (FDA) has approved AstraZeneca’s Baxfendy (baxdrostat) as a first-in-class hypertension therapy designed for patients

A new Ebola outbreak in Congo has triggered urgent health warnings across Central Africa after officials reported 246 suspected cases

A major new study on antidepressants in pregnancy is offering reassurance to millions of families concerned about how antidepressants will

A historic healthcare effort has led to a major shift in women’s health terminology. The condition PCOS has officially been

The Hantavirus outbreak on cruise ship MV Hondius is continuously growing. It has prompted international health agencies to launch large-scale

The UK public health officials have issued an urgent alert following a Hepatitis A outbreak in Wales, after several linked

Eli Lilly and Company is investing another $4.5 billion into its Indiana operations as the drugmaker expands production of obesity

The U.S. Food and Drug Administration (FDA) has authorized the marketing of four new electronic nicotine delivery systems (ENDS), signaling

The U.S. Food and Drug Administration (FDA) blocks publication of vaccine research on several studies examining their safety, sparking debate